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a  b  s  t  r  a  c  t
The  ferret  is an  excellent  model  for  many  human  infectious  diseases  including  inﬂuenza,  SARS-CoV,
henipavirus  and  pneumococcal  infections.  The ferret  is  also used  to study  cystic  ﬁbrosis  and  various
cancers,  as  well  as reproductive  biology  and  physiology.  However,  the  range  of  reagents  available  to
measure  the  ferret  immune  response  is  very  limited.  To  address  this  deﬁciency,  high-throughput  real
time  RT-PCR  TaqMan  assays  were  developed  to  measure  the  expression  of  ﬁfteen  immune  mediators
associated  with  the innate  and  adaptive  immune  responses  (IFN,  IFN, IFN,  IL1,  IL1,  IL2,  IL4,  IL6,
IL8,  IL10,  IL12p40,  IL17,  Granzyme  A,  MCP1,  TNF),  as well  as  four  endogenous  housekeeping  genes
(ATF4,  HPRT,  GAPDH,  L32).  These  assays  have  been  optimized  to  maximize  reaction  efﬁciency,  reduceytokine
ene
aqMan
the  amount  of  sample  required  (down  to 1  ng RNA  per  real time  RT-PCR  reaction)  and  to  select  the most
appropriate  housekeeping  genes.  Using  these  assays,  the  expression  of each  of the  tested  genes  could  be
detected in  ferret  lymph  node  cells  stimulated  with  mitogens  or infected  with  inﬂuenza  virus  in vitro.
These  new  tools  will  allow a more  comprehensive  analysis  of the  ferret  immune  responses  following
infection  or  in  other disease  states.
© 2014  The  Authors.  Published  by  Elsevier  B.V. This  is  an  open  access  article  under  the  CC  BY-NC-ND. Introduction
Ferrets are an outbred population widely used to study inﬂuenza
irus infection (Belser et al., 2011; Laurie et al., 2010; Rockman et al.,
012; Hurt et al., 2010) as well as a range of other diseases, includ-
ng SARS-coronavirus (CoV) (reviewed in (Roberts et al., 2008))
nd henipaviruses, such as infection with Hendra virus and Nipah
irus (Bossart et al., 2009; Pallister et al., 2009, 2011; Geisbert
t al., 2012). The anatomical and physiological similarity between
uman and ferret lungs also enables ferrets to be used as a model
o study lung carcinomas (reviewed in Baric et al., 2013). Recently,
bsence of the cystic ﬁbrosis transmembrane conductance regula-
or (CFTR) was associated with spontaneous disease induction in
he lung and pancreas in ferrets, showing similar pathology to that
∗ Corresponding author. Tel.: +61 3 9342 9313.
E-mail address: Karen.laurie@inﬂuenzacentre.org (K.L. Laurie).
ttp://dx.doi.org/10.1016/j.jviromet.2014.04.014
166-0934/© 2014 The Authors. Published by Elsevier B.V. This is an open access article unlicense (http://creativecommons.org/licenses/by-nc-nd/3.0/).
of cystic ﬁbrosis in humans (Sun et al., 2010, reviewed in Keiser and
Engelhardt, 2011). The broad utility of this model is highlighted by
the use of ferrets to study pneumococcal transmission, reproduc-
tive biology and human fetal brain development (reviewed in Baric
et al., 2013).
While the ferret is a good model for human respiratory virus
infections, reagents to identify ferret leukocytes and immune
mediators are limited. Studies have identiﬁed cross-reactive anti-
bodies that recognize populations of ferret leukocytes, such as CD8,
CD11, CD44 and CD25, and cytokines IFN,  TNF, IL4 and IL8
(Rutigliano et al., 2008; Martel and Aasted, 2009; Pillet et al., 2011).
Cloning and sequencing of ferret cytokine genes have enabled
molecular approaches targeting the corresponding mRNAs (von
Messling et al., 2006; Danesh et al., 2008; Nakata et al., 2008; Ochi
et al., 2008; Qin et al., 2013). Expression of cytokine and chemokine
genes has been assessed in ex vivo samples following infection of
naïve or vaccinated ferrets with inﬂuenza virus or SARS-CoV by
microarray analysis (Cameron et al., 2008; Fang et al., 2010; Rowe
der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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t al., 2010). Cytokine and chemokine gene proﬁles have also been
ssessed ex vivo and in in vitro epithelial cultures using SYBR green
eal time RT-PCR assays (Svitek and von Messling, 2007; Cameron
t al., 2008; Danesh et al., 2008, 2011; Svitek et al., 2008; Kim et al.,
009; Fang et al., 2010; Hamelin et al., 2010; Kobinger et al., 2010;
owe et al., 2010; Kang et al., 2011; Meunier and von Messling,
011, 2012; Pillet et al., 2011; Huang et al., 2012; Maines et al., 2012;
eunier et al., 2012; Belser et al., 2013; Zeng et al., 2013). TaqMan
hemistry incorporates target-speciﬁc ﬂuorescent labeled probes
nabling multiple genes can be assessed in a single real time PCR
eaction (Giulietti et al., 2001). To date, TaqMan real time RT-PCR
ssays have only been developed for a smaller number of ferret-
peciﬁc gene targets (Nakata et al., 2009; Suguitan et al., 2012).
To enable a broader characterization of the immune response
n the ferret model, we developed a panel of TaqMan assays to
etect mRNA of ﬁfteen ferret cytokines, chemokines and immune
ediators (IFN, IFN, IFN,  IL1, IL1,  IL2, IL4, IL6, IL8, IL10,
L12p40, IL17, granzyme A, MCP-1, TNF) and four housekeeping
enes (ATF4, GAPDH, L32 and HPRT). The cytokine and chemokine
roﬁle induced by stimulation of ferret leukocytes with mitogens
r inﬂuenza virus was also assessed to investigate the relevance of
he ferret immune response to human infection studies.
. Materials and methods
.1. Design of ferret cytokine and housekeeping gene primers and
robes
Sequences for cytokine, chemokine and housekeeping genes
f multiple species were obtained from Genbank (http://www.
cbi.nlm.nih.gov/genbank) and aligned. Regions of conservation
ere identiﬁed and primers were designed using PrimerSelect
DNASTAR Lasergene8, Madison, USA) or PrimerExpress (Applied
iosystems, California, USA) to amplify the region from ferret
DNA. Cloned genes were sequenced and TaqMan real time PCR
rimers and probes designed using PrimerExpress. All oligonu-
leotide primers and probes used in this study, including those
reviously published, are listed in Table 1. Primers for IFN were
esigned to amplify multiple subtypes (1–12) (Easlick et al., 2010;
illyer et al., 2012).
.2. Oligonucleotide primer and probe generation
Lyophilized oligonucleotide primers were synthesized by
eneworks (Adelaide, Australia) and dissolved in nuclease-free
ater (Promega, Madison, USA) at 100 M.  All TaqMan® MGBTM
robes were synthesized by Applied Biosystems with a 5′reporter
ye (either FAM, NED or VIC) and a 3′non-ﬂuorescent quencher
NFQ).
.3. Ferrets
Adult male and female ferrets (weight 500–1500 g) were pur-
hased from independent breeders and housed at CSL Limited
Victoria, Australia) using services provided under a Support Ser-
ices Agreement. Serum samples were tested by hemagglutination
nhibition assay to ensure seronegativity (titer <10) to currently
irculating inﬂuenza strains before use. Experiments using fer-
ets were conducted with approval from the CSL Limited/Zoetis
ustralia Animal Ethics Committee, in accordance with the Aus-
ralian Government National Health and Medical Research Council
ustralian code of practice for the care and use of animals for sci-
ntiﬁc purposes (NHMRC, 2013).cal Methods 205 (2014) 38–52 39
2.4. Inﬂuenza virus
A/Tasmania/2004/2009 (A(H1N1)pdm09) inﬂuenza virus was
passaged in the allantoic cavity of embryonated hen’s eggs and
stored in aliquots at −80 ◦C. To heat inactivate, virus was incubated
at 60 ◦C for 30 min.
2.5. In vitro culture of ferret lymph node cells with mitogens or
inﬂuenza virus
Retropharyngeal lymph nodes were collected from naïve fer-
rets and placed in RPMI-1640 AQ mediaTM (Sigma–Aldrich, New
South Wales, Australia) supplemented with 10% (v/v) fetal calf
serum (Interpath Services, Victoria, Australia), 2 mM L-glutamine
(SAFC Biosciences, USA), 50 U/ml penicillin/50 g/ml streptomycin
(Sigma–Aldrich) (complete-RPMI). Single cell suspensions were
made by mashing the tissue and passing through a sterile 40 M
cell strainer (BD, San Jose, USA). Cell suspensions were washed
twice then resuspended in complete-RPMI. Lymph node cells
from each ferret (5 × 106 per well) were plated in a 24-well
plate in 1 ml  complete-RPMI with or without 10 l of live or
heat-inactivated virus (104 TCID50) or 5 g/ml Concanavalin A
(ConA), Phytohaemagglutinin (PHA-P), Lipopolysaccharide (LPS),
Ionomycin (Iono) or Phorbol 12-myristate 13-acetate (PMA) (all
from Sigma–Aldrich) in duplicate or triplicate. Cell cultures were
incubated at 37 ◦C in 5% CO2 in a humidiﬁed incubator for the
indicated periods.
2.6. RNA extraction
Total RNA was  extracted from cultured cells using the RNeasy®
Mini kit (Qiagen, Victoria, Australia) according to the manufac-
turer’s instructions. Brieﬂy, cells from a single well were pelleted
and resuspended in 600 l RLT buffer. The sample was vortexed
and then run through a QIAshredder column. RNA was extracted
from the supernatant using the Animal Cells Spin protocol, with-
out on-column DNase digestion and eluted with a 30 l volume.
RNA purity was assessed (A260/A280) using a Nanodrop 1000 spec-
trophotometer (Thermo Scientiﬁc, Massachusetts, USA). RNA was
stored at −80 ◦C.
2.7. Reverse transcription
For removal of genomic DNA, 800 ng RNA was incubated with
2 units DNase I (RNase-free) (New England Biolabs, Massachusetts,
USA) in DNase reaction buffer (ﬁnal volume 10 1) at 37 ◦C for
10 min. The reaction was terminated by the addition of EDTA (ﬁnal
concentration 5 mM,  Sigma–Aldrich) and incubation at 75 ◦C for
10 min. cDNA was generated using the Superscript III First Strand
synthesis System for RT-PCR (Invitrogen, California, USA) with
random hexamer primers, according to the manufacturer’s instruc-
tions. RNaseH treatment was  performed. A simultaneous reaction
without the reverse transcription enzyme was  performed in par-
allel to generate a ‘-RT’ control. The reaction volume resulted in
10 ng initial RNA/l ﬁnal cDNA preparation for culture samples,
except at points indicated in the text, where 1 ng initial RNA/l
ﬁnal cDNA preparation was used. cDNA standards were generated
in parallel with cDNA test samples for each experiment. cDNA stan-
dards were prepared using RNA pooled from a range of test samples
within each experiment, with at least 80 l of 100 ng initial RNA/l
ﬁnal cDNA standard prepared. Ten-fold and two-fold serial dilu-
tions (ﬁve dilutions of each) were prepared and used for standard
curve generation for efﬁciency calculations. cDNA was stored at
−20 ◦C.
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Table 1
Oligonucleotide primer and probe sequences used in this study. Primers and probes developed for the TaqMan real time RT-PCR assay in this study are highlighted in bold italics. Primers (and probes) from other published real
time  RT-PCR studies, TaqMan and SYBR Green, are indicated. Primers used to clone inserts for plasmid controls are also indicated, and referenced as appropriate.
Gene target Forward primer 5′ → 3′ Reverse primer 5′ → 3′ Probe Use Reference
IL1 CTGAAACCTCAAAGACATCTCATCTT GCTGGCTGCCACCATCA FAM-CCTTCAAGGAGGATGTG- MGBNFQ TaqMan This study
IL1  TTCTCTGAATCAGAAATCCTTCTATGAT CTCTTACAAAGAGAGTAAACATTCATTTGG Cloning This study
IL1 CCTGGTGCTGTATAACTCGTATGAG TTGGTTCACACTAGTTCCGTTGA VIC-TCGGGCGCTCCAC- MGBNFQ TaqMan Reverse primer
matches (Fang et al.,
2010; Rowe et al.,
2010)
IL1 AGATGAAGTGCTGCTTCCAAGAC GTGCTGATGTACCAGTTGGGAAA Cloning This study
IL1 GGACTGCAAATTCCAGGACATAA TTGGTTCACACTAGTTCCGTTGA SYBR green Fang et al. (2010) and
Rowe et al. (2010)
IL2 GTTAAAAATTATGAGAGCCCCAGGA TTGAGTTCTTCTGCTAGACATTGAAGA FAM-CTACATGCCCAAGAAG-MGBNFQ TaqMan This study
IL2  GCAACTCTTGTCTTGCATCGTAC TCAAGTCAGTGTTGAGAAGATGC Cloning This study
IL2  TGCTGCTGGACTTACAGTTGCTCT CAATTCTGTGGCCTTCTTGGGCAT SYBR green Svitek and von
Messling (2007)
IL4 CCAACAGATTGCTCAGAGGACTT CACCGAACAGGTCATGTTTGC 6FAM-CAGGAACCTCAGGAACAT-MGBNFQ TaqMan assay This study
IL4  GATCTATTAATGGGTCTCACCTC CAGCTTCAATGCCTGTAGTATTTCTG Cloning This study
IL4  CGTTGAACATCCTCACAGCGAGAAAC TTGCCATGTTCCTGAGGTTCCTGTGA SYBR green Svitek and von
Messling (2007)
IL4 TCACCGGCACTTTCATCCACGGACATAACTT GAGCTGCTGAAGCACAGTTGCAGCTCTGC SYBR green Maines et al. (2012)
IL4 TCACCGGCACTTTCATCCA TTCTCGCTGTGAGGATGTTCA SYBR green Fang et al. (2010)
IL6 GCAGAGAACAACCTAAATCTTCCAA TGATTGAATTGAGACTGGAAGCA 6FAM-CTGGCAGAAGAGGAC-MGBNFQ TaqMan This study
IL6  CAAATGTGAAGACAGCAAGGAGGCA TCTGAAACTCCTGAAGACCGGTAGTG SYBR green,
cloning
Svitek and von
Messling (2007)
IL6 CAAGTGGCTGAAACACGTAACAA GGCTGAACTGCAGGAAATCC FAM-TCACCTCATCCTACGGAGCCTTG-TAMRA TaqMan Nakata et al. (2009)
IL8 GGCACCTTGCATCAACATGA AAGCAGGAAAACTGCCAAGAGA 6FAM-TTCCAAGCTGGCTGTTG-MGBNFQ TaqMan This study
IL8  CAAGAGCCAGGAAGAAACCAGACC TGATTCTTGGATACCACAGAGAATG Cloning This study
IL8  AACCCACTCCACGCCTTTCCATC GGCACACCTCTTTTCCATTGAC SYBR green Maines et al. (2012)
IL10 GCTGCGGCGCTGTCA CTCCACCGCCTTGCTCTTAT VIC-CGATTTCTGCCCTGTGAG-MGBNFQ TaqMan This study
IL10  CCTTCGGCAGGGTGAAGACTTTC ATGTCAAACTCACTCATGGCTTTGTAG Cloning This study
IL10  TCCTTGCTGGAGGACTTTAAGGGT TCCACCGCCTTGCTCTTATTCTCA SYBR green Svitek and von
Messling (2007)
IL10 CGAGAACCACGACCCAGAA CCGCAGGGTCTTCAGCTTT FAM-TCAAGGAGCACGTGAACTCGCTGG-TAMRA TaqMan Nakata et al. (2009)
IL12p40 GGTGCTATTCACAAGCTCAAGTATG GGTTTGATGATGTCCCTGATGA VIC- TACACCAGCAGCTTC-MGBNFQ TaqMan,
cloning
This study
IL12p40  ATCGAGGTTGTGGTGGGTGCTATT TAGGTTCATGGGTGGGTCTGGTTT SYBR green Svitek and von
Messling (2007)
IL17 GGACGGTAAACTACCACATGAACTC AGACTCCCTTCGCAGAACCA VIC-TCCCCATCCAGCAAGA-MGBNFQ TaqMan This study
IL17  CGCAATGAGGACCCTGAGAGA ggtgacacaggtgcagcccac Cloning This study
Granzyme A GGATCCTCCCTCTCCCTAAGAA CCCAGCCTGCAACTTGACA VIC-ATGATGTCAAACCCGAAAC-MGBNFQ TaqMan This study
Granzyme A ACTGGGTGTTGACTGCAGCTC ACATATCAGAGGGCTTCCAGAATC Cloning This study
MCP1  GCAGCAAGTGTCCCAAAGAAG GACTGGGGTCAGCGCAGAT FAM-ATCCTCAAGACATTCCT-MGBNFQ TaqMan This study
MCP1  GCAGCAAGTGTCCCAAAGAAG gctttgcagtttgggtttgg Cloning b This study
CCL2  (MCP1) GCTCCCTATTCACTTGCTGTTTC GATTCGATAGCCCTCCAGCTT SYBR green Rowe et al. (2010)
TNF TGCCATCAGACGGGCTGTA ACATCCTCGGCCCTTGAAG VIC-CTTATCTACTCGCAGGTCC-MGBNFQ TaqMan This study
TNF  TGGAGCTGACAGACAACCAGCTAA TGATGGTGTGGGTAAGGAGCACAT SYBR green,
cloning
Svitek and von
Messling (2007)
TNF CCAGATGGCCTCCAACTAATCA GGCTTGTCACTTGGAGTTCGA SYBR green Fang et al. (2010) and
Rowe et al. (2010)
TNF ATGTTGTAGCAAACCCTGAAGCT ATTGGCCAGGAGGGCATT FAM-ACTCCAATGGCTGAGCCGACGTG-TAMRA TaqMan Nakata et al. (2009)
IFNa TCCATCCTGAGGAACTACTTCCAG AGGCACAAGGGCTGTATTGC 6FAM-GAATCTCCCTCTATCTGC-MGBNFQ TaqMan This study
IFNa CTCAGCWGCCACTMCCTC CATGATCTCTGCTCGGACCAT Cloning This study
IFN  ATGCTCCTGCGACAAATGAGGAGA TTCTGCAGCTGCTTGCTGTCAAAC SYBR green Svitek and von
Messling (2007)
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2.8. Polymerase chain reaction (PCR)
Ampliﬁcation of gene-speciﬁc products was performed using
Platinum® Taq DNA Polymerase High Fidelity (Invitrogen) accord-
ing to the manufacturer’s instructions. Reactions were run on a
S1000TMThermal Cycler (Bio-Rad Laboratories Pty Ltd., New South
Wales, Australia).
2.9. Cloning of ferret genes
Total RNA was extracted from stimulated ferret cell cultures,
reverse transcribed and ferret genes ampliﬁed by conventional and
TaqMan real time PCR, using primers indicated in Table 1. Both
cDNA and ‘no RT’ control samples were run to ensure the speciﬁcity
of the ampliﬁcation. The matrix inﬂuenza gene was ampli-
ﬁed from RNA extracted from virus isolate A/California/7/2009
(A(H1N1)pdm09). The products were agarose gel-puriﬁed using
the QIAquick gel extraction kit (Qiagen) according to the man-
ufacturer’s instructions. Puriﬁed DNA was quantiﬁed and ligated
into pGEM®-T Easy vector (Promega) (IFN, IL2, IL4, IL6, IL8, IL10,
IL12p40, IL17, MCP1, TNF, ATF4, HPRT, GAPDH, L32, Matrix) or
pCRTM4Blunt-TOPO® vector (Invitrogen) (IFN, IFN, IL1, IL1,
Granzyme A) according to manufacturer’s instructions. Ligation
reactions were transformed into One Shot® TOP10 chemically
competent E. coli (Invitrogen) by heat shock according to the man-
ufacturer’s protocol. Positive transformants were identiﬁed by PCR
using M13  primers (Promega) and gene-speciﬁc primers. Plasmid
DNA was  isolated from bacterial cultures using the QIAprep Spin
miniprep kit (Qiagen) according to the manufacturer’s instructions.
2.10. Real time PCR assay
The generation of oligonucleotide dimers for each TaqMan
primer pair was assessed using Power SYBR® Green PCR Master-
Mix  (Applied Biosystems) with melting curve analysis, according
to the manufacturer’s instructions. Primers which resulted in
oligonucleotide dimer generation were redesigned and retested. A
comparison between primer pairs was also performed using Power
SYBR® Green PCR MasterMix without a melting curve, according
to the manufacturer’s instructions. All other real time PCR assays
were performed using the TaqMan® Fast Universal PCR Master
Mix  (2×),  No AmpErase UNG (Applied Biosystems), according to
the manufacturer’s instructions. One microliter cDNA sample was
assayed per reaction. Each reaction consisted of 1 cycle of 95 ◦C for
20 s, followed by 50 cycles of 95 ◦C for 3 s and 60 ◦C for 30 s. Real
time PCR runs for each gene included cDNA standards (10-fold and
2-fold dilutions, in duplicate), DNA plasmid controls (10-fold dilu-
tions; 5 dilutions), no template control and test samples. When test
samples were run over multiple plates for a single gene, DNA plas-
mid  controls were included on each plate and the same mastermix
preparation was  used for all PCR plates. DNA plasmid controls were
reproducible (<1 Ct difference) between plates. All real time PCR
reactions were run on an Applied Biosystems 7500 Fast Real-Time
PCR system using the 7500 Fast System Software, Version 1.4.0.25
(Applied Biosystems). Data were analyzed using 7500 Fast System
Software, Version 1.4.0.25 except for plasmid DNA efﬁciency calcu-
lations which were determined using 7500 Fast System Software
Version 2.0.5.
2.11. Calculations of reaction efﬁciency, housekeeping gene
stability and fold change of gene expressionThe efﬁciency of each gene ampliﬁcation was  calculated by
plotting the average Ct (y-axis) against the logarithm of the input
amount of RNA/l cDNA (x-axis). Both a 10-fold dilution series
and a 2-fold dilution series were used for each gene and RNA
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Table 2
Ferret genes ampliﬁed in this study and sequence similarly to other published ferret experimental and predicted sequences by BLASTn. Features of the BLASTn alignments
are  indicated. Note that the aligned sequences are divided into sequences submitted from laboratory-derived experimental data as well as sequences from the ferret genome
which  have been predicted and designated using the gene prediction tool.
Gene GenBank accession #
generated for this study
Size of gene generated
for this study (bp)
BLASTn results
No. of alignmentsa Query coverage (%)b Identity (%)c GenBank accession numbers
Experimental
mRNA sequences
Predicted mRNA
sequencesd
IL1 KJ831213 953 1 95 98 – XM 004771000.1
IL1  KJ831212 737 3 85 99–100 AB301555.1,
EU835490.1
XM 004826192.1
IL2  KJ831211 232 2 98 99 KC585003.1 XM 004747973.1
IL4  KJ831210 413 4 95–100 99–100 EF49062.1,
EF368210.1,
KC585004.1
XM 004745005.1
IL6  KJ831209 143 5 100 97–100 EF492063.1,
EF368209.1,
EU753358.1
XM 004743357.1,
XM 004743356.1
IL8  KJ831208 384 4 77–100 99–100 EU835489.1,
EU477256.1
AB300565.1,
XM 004766277.1
IL10  KJ831207 349 2 100 100 EF368212.1 XM 004756192.1
IL12p40 KJ831206 70 2 97 100 EF368213.1 XM 004737709.1
IL17  KJ831205 216 1 99 99 – XM 004771883.1
Granzyme A KJ831203 464 1 98 99 – XM 004744658.1
MCP1  KJ831216 135 1 100 99 – XM 004747089.1
TNF  KJ831217 119 6 100 100 KC713805.1,
EF492065.1,
EF368211.1
XM 004826757.1,
XM 004781005.1,
XM 004781004.1
IFN KJ831201 471 43 100 88–99 EU863622.1,
EU863621.1,
EU863616.1,
EU863624.1,
EU863619.1,
EU863620.1,
EU863617.1,
EU091340.1,
EU863615.1,
EU863614.1,
EU863613.1,
EU543213.1,
EU395773.1,
EU863618.1,
EU863623.1,
EF368207.1
XM 004761809.1,
XM 004803999.1,
XM 004761818.1,
XM 004803994.1,
XM 004804009.1,
XM 004761812.1,
XR 200135.1,
XM 004804015.1,
XM 004761833.1,
XM 004804014.1,
XM 004804000.1,
XM 004761810.1,
XM 004761838.1,
XM 004761834.1,
XM 004804013.1,
XR 200137.1,
XM 004761835.1,
XR 203184.1,
XM 004804001.1,
XM 004761836.1,
XM 004761811.1,
XM 004803995.1,
XM 004804010.1,
XM 004761817.1,
XM 004761815.1,
XM 004761814.1,
XM 004761840.1
IFN  KJ831215 524 3 99 98–100 EF368208.1,
EF581890.1
XM 004761820.1
IFN KJ831214 451 4 97–100 99 EF492064.1,
AB300566.1,
EF368214.1
XM 004752468.1
ATF4  KJ831200 143 4 100 99–100 – XM 004743292.1,
XM 004825436.1,
XM 004786859.1,
XM 004779758.1
HPRT  KJ831202 125 2 98 98 – XM 004815015.1,
XM 004778420.1
GAPDH KJ831204 250 4 100 98–99 EF392835.1 XM 004766704.1,
XM 004766703.1,
XM 004766702.1
L32  KJ831218 104 1 96 97 – XM 004738566.1
a BLASTn sequences that aligned with the ferret sequence generated in this study.
b Relationship between the length the of the BLASTn sequence and the ferret sequence generated in this study. <100% indicates that the BLASTn sequence is shorter. Range
for  all BLASTn sequences is indicated.
c Range for all BLASTn sequences is indicated.
d Predicted using the NCBI eukaryotic gene prediction tool, Gnomon.
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Fig. 1. Development of TaqMan assay to detect expression of ferret immune mediators and housekeeping genes using plasmid DNA standards. (A) The speciﬁcity of all
primer/probe sets was tested against all DNA plasmid standards (1 pg) by TaqMan real time PCR and assessed by gel electrophoresis. An example is shown. (B) The efﬁciency
of  each reaction was determined using a 10-fold dilution standard curve. Cytokine and chemokine (black circles) and housekeeping (white circles) genes are shown. The
mean  efﬁciency for all genes is indicated by the horizontal line. The reaction efﬁciency (E) is indicated with the corresponding % efﬁciency, with the ideal value ‘E = 2’ and the
acceptable range (1.9–2.1), indicated. (C) One or two primer/probe sets were combined in a real time PCR reaction and assayed against each of the single target genes. (D)
One  primer/probe set was  assayed against the target gene in a pool (four to seven plasmids) or alone. (E) One or two primer/probe sets were combined in a real time PCR
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et. Real time PCR efﬁciency (E) = (10−1/slope) for 10-fold dilution
eries (Pfafﬂ, 2004) and (2−1/slope) for 2-fold dilution series. % real
ime PCR efﬁciency = (E − 1) × 100. If the standard deviation for the
fﬁciencies determined using 10-fold and 2-fold dilution series fell
ithin 8%, the average efﬁciency was used in all calculations. If the
tandard deviation was >8%, the efﬁciency calculated using 2-fold
ilutions was used. The geometric mean of the efﬁciencies for the
ndicated genes was used for the housekeeping gene efﬁciency.
he gene stability of housekeeping genes was calculated using
eNorm in qbase+ Version 2.5 (Biogazelle) (Vandesompele et al.,
002). The fold change of expression of a gene was calculated using
elative quantitation with kinetic PCR correction (Pfafﬂ, 2004).
old change = (Etarget)Ct target (control−test)/(EHKP)Ct HKP (control−test)
here ‘HKP’ was the geometric mean of all housekeeping genes
or each data point as indicated in ﬁgure legends and ‘Ct’ = Ct
ontrol – Ct test. “Undetermined’ data points in cytokine gene
xpression were assigned a Ct of “40” to enable calculation of fold
hange and are indicated in ﬁgure legends. The control sample for
ultures was unstimulated cells cultured in complete-RPMI. in triplicate, with mean and standard deviation indicated. *p < 0.05.
2.12. Statistics
The ability to perform duplex real time PCR was assessed using
two tailed t-test. Data were analyzed using R software (Version
2.15.3 (2013-03-01)) (Team, 2013). Expression of target genes in
cultured cells was  compared using one-way ANOVA and Tukey’s
post hoc test (only differences to unstimulated cells are indicated).
The mean of duplicate or triplicate wells was calculated and used
as a single value for each ferret. *p < 0.05, **p  < 0.01, ***p < 0.001.
3. Results
3.1. Development of a two-step TaqMan real time PCR assay to
measure expression of ferret immune mediator and housekeeping
genesCytokine, chemokine and housekeeping genes were ampliﬁed
from total mRNA generated from cultures of ferret lymph node
cells using primers targeting conserved regions of each gene. All
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Table 3
Comparison of the sensitivity of TaqMan and SYBR Green real time PCR assays. All reactions were performed with the same plasmid standard, except in cases where the
appropriate plasmid standard encompassing both primer sets was  not available, and a cDNA sample was used instead. The same samples were used to compare the TaqMan
assays  in this study with either previously published TaqMan assays or previously published SYBR Green assays for an individual gene. Individual lines indicate different
experiments.
Gene target Sensitivity of real time reactiona References for other published studies
TaqMan primer/probes
from this study
TaqMan primer/probes from
other published studies
SYBR Green primers from other
published studies
TaqMan assay TaqMan Assay SYBR Green assay
Copy
number/RNA
amount
Average
Ct ± std dev
Copy
number/RNA
amount
Average
Ct ± std dev
Copy
number/RNA
amount
Average
Ct ± std dev
IL1 20.8b 34.8 ± 0.1 n.a. n.a.
IL1 21.9b 33.8 ± 0.3 21.9b 35.3 ± 0.2 Fang et al. (2010) and Rowe et al. (2010)
IL2 26.3b 34.6 ± 0.3 26.3b 29.9 ± 0.8 Svitek and von Messling (2007)
IL4 26.6b 34.7 ± 0.5 26.6b 35.3 ± 0.4 Maines et al. (2012)
IL4 26.6b 34.7 ± 0.5 26.6b 33.2 ± 0.1. Svitek and von Messling (2007)
IL6 28.9b 36.8 ± 0.3 28.9b 33.6 ± 0.9 Svitek and von Messling (2007)
IL6 0.1 ng 38.2 ± 0.6 0.1 ng 38.7 ± 0.7 Nakata et al. (2009)
IL8 26.9b 37.1 ± 0.6 26.9b 34.0 ± 0.4 Maines et al. (2012)
IL10 27.1b 35.0 ± 0.3 27.1b 33.9 ± 0.9 Svitek and von Messling (2007)
IL10 27.1b 33.3 ± 0.5 27.1b 34.6 ± 0.5 Nakata et al. (2009)
IL12p40 29.6b 33.2 ± 0.4 n.a.d n.a.d
IL12p40d 1 ng 33.9 ± 0.4 1 ng 34.6 ± 1.2 Svitek and von Messling (2007)
IL17 28.2b 33.9 ± 0.4 n.a. n.a.
Granzyme A 22.8b 35.3 ± 0.7 n.a. n.a.
MCP1  29.0b 34.9 ± 0.2 n.a.d n.a.d
MCP1d 0.1 ng 33.3 ± 0.3 1 ng 34 ± 0.9 Rowe et al. (2010)
TNF 29.1b 34.1 ± 0.6 29.1b 31.1 ± 0.6 Svitek and von Messling (2007)
TNFd 0.1 ng 33.7 ± 0.6 0.1 ng 34.5 ± 0.7 Fang et al. (2010) and Rowe et al. (2010)
TNF d 0.1 ng 34.6 ± 0.5 0.1 ng 35.0 ± 0.6 Nakata et al. (2009)
IFN 22.9b 34.7 ± 0.8 22.9b 34.5 ± 0.8 Svitek and von Messling (2007)
IFN 22.5b 35.7 ± 0.7 22.5b 31.6 ± 0.4 Maines et al. (2012)
IFN 26.3b 35.1 ± 0.5 26.3b 33.6 ± 1.1 Svitek and von Messling (2007)
IFN 26.3b 34.8 ± 0.2 26.3b 35.9 ± 0.1 Nakata et al. (2009)
Matrix 23.3b 37.2 ± 0.8 n.a. n.a.
ATF4  28.9b 33.9 ± 0.5 n.a. n.a.
HPRT  29.1b 35.9 ± 0.3 n.a. n.a.
GAPDH <10c 37.6 ± 0.9 2.8c 37.8 ± 1 Svitek and von Messling (2007)
GAPDHd 0.3 ng 33.4 ± 1.5 0.03 ng 31.7 ± 0.6 Nakata et al. (2009)
L32 29.3b 36.6 ± 0.7 n.a. n.a.
n.a.: not applicable.
a Sensitivity refers to the minimum number of copies detected after serial ten-fold dilutions of DNA plasmid, in all triplicates. All three replicates must have a detectable
Ct  value for inclusion.
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(Copy number is equivalent to 0.0001 pg DNA plasmid standard.
c Copy number is equivalent to 0.00001 pg DNA plasmid standard.
d Plasmid did not overlap with previously published primer sequence.
enes cloned in this study were sequenced and the sequences run
n BLASTn whereby they matched other published and predicted
equences for the corresponding ferret gene on GenBank, especially
hose derived from the ferret genome project (Di Palma et al., 2013)
Table 2). Sequences generated in this study were also translated
nd all sequences aligned to known sequences of the correspond-
ng proteins from other species in GenBank (data not shown). All
rimer/probe sets for the TaqMan real time PCR assay (Table 1)
ere tested to ensure speciﬁcity and optimum efﬁciency using
lasmid DNA standards. The absence of non-speciﬁc amplicons was
eriﬁed for all primer/probe sets (Fig. 1A). The % efﬁciency of each
rimer/probe set was consistent and between 94 and 103% which is
quivalent to an efﬁciency of 1.94–2.03 (Fig. 1B), indicating that the
emplate doubled after each cycle during exponential ampliﬁca-
ion. The correlation co-efﬁcient for all samples was between 0.980
nd 0.999 (data not shown). The sensitivity of the primer/probe sets
or each gene was consistent across the different TaqMan assays,
ith all genes detected down to 0.0001 pg DNA plasmid (aver-
ge 25.2 RNA copies), except GAPDH, which was detected down to
.00001 pg DNA (2.5 RNA copies) (Table 3). The limits of detection
ere consistent for previously published TaqMan primer/probes
ets (Nakata et al., 2009) and all tested SYBR Green primer sets
Svitek and von Messling, 2007; Fang et al., 2010; Rowe et al., 2010;Maines et al., 2012) when analyses were performed using the same
samples (Table 3). There was  no change in the sensitivity of the
assay when primer/probes were mixed in the indicated duplex real
time PCR reactions (Fig. 1C), or when plasmid samples were pre-
pared in pools (Fig. 1D), or a combination of both duplex real time
PCR reactions and sample pools (Fig. 1E), except for L32, which was
less sensitive when assayed with other genes (Fig. 1E).
3.2. Optimization of two-step real time PCR assay using RNA from
cultured lymphoid cells
To enable comparison between samples from multiple ferrets,
the expression of all genes was determined as a fold change, using
the calculation for relative quantiﬁcation to housekeeping gene(s),
with kinetic PCR efﬁciency adjustment (Pfafﬂ, 2004). As this equa-
tion relies on consistency between samples in the RNA quantity
assayed, and the optimum reaction efﬁciency, as well as minimal
ﬂuctuation in the expression of housekeeping genes (endogenous
controls) (Peters et al., 2007; Mane et al., 2008; Bruder et al., 2010),
these parameters were optimized using RNA extracted from cul-
tured ferret lymph node cells stimulated with mitogens or with
inﬂuenza virus.
L.A. Carolan et al. / Journal of Virological Methods 205 (2014) 38–52 45
A
B C
18
22
26
30
34
38
rea l time 1
rea l time 2
rea l time 3
rea l time 4
r2=0.992 8
C
t
18
22
26
30
34
38
reverse transc ription  1
reverse transc ription  2
reverse transc ription  3
r2=0.990 5
C
t
RNA quantity (ng)
0.01         0.1             1            10            100 0.01         0.1             1            10            100
none ConA PHA Iono PMA LPS
0
4
8
12
to
ta
l 
R
N
A
 p
e
r 
w
e
ll 
(
g
)
none virus HI  virus
stimulus
Fig. 2. Quantiﬁcation of total RNA isolated from cultured ferret lymphoid cells and assessment of variability in reverse transcription and real time PCR assay steps. (A) Cells
from  naïve ferret lymph nodes were cultured with or without the indicated mitogens or with inﬂuenza virus for 24 or 48 h, respectively. Each point indicates the average
amount of RNA isolated from duplicate or triplicate culture wells of cells from a single ferret. Total RNA was extracted and quantiﬁed by spectrophotometry. The mean for
each  group is indicated by horizontal bar. (B) cDNA was reverse transcribed from the same RNA samples on three separate occasions. All samples were assessed in the same
r ransc
( ulated
1
m
T
t
d
h
r
w
(
s
l
a
r
a
e
r
c
r
s
r
F
v
I
t
d
t
Teal  time PCR assay detecting the housekeeping gene ATF4. (C) cDNA was  reverse t
B,  C) Individual data points represent each experiment. The line of best ﬁt was calc
As the RNA quantity varied between samples (range
.39–11.17 g/well, Fig. 2A), we ﬁrst determined the mini-
um  amount of RNA for use in the TaqMan real time RT-PCR assay.
he reproducibility of both reverse transcription (Fig. 2B) and real
ime PCR (Fig. 2C) steps was assessed separately for samples with
ifferent amounts of RNA. A minimum of 1 ng total RNA produced
ighly reproducible results for both reverse transcription and
eal time PCR steps (standard deviation <0.4Ct) and the Ct value
as able to detect gene expression (Fig. 2B and C) where Ct
cycle threshold) is the cycle number at which the ﬂuorescent
ignal of the reaction crosses the threshold to exceed background
evel. A set of cDNA standards was generated from the mitogen-
nd inﬂuenza virus-stimulated ferret lymph node cells and the
eaction efﬁciency for all genes determined (examples of graphs
nd calculations for efﬁciency are shown in Fig. 3A, compilation of
fﬁciencies for all genes is shown in Fig. 3B and C). Although the
eaction efﬁciencies clustered for each of the ferret lymph node
DNA preparations (mitogen or virus stimulation in Fig. 3B and C,
espectively), the efﬁciencies using the 10-fold dilutions of cDNA
amples were more broadly spread than for the plasmid prepa-
ations (compare 10-fold dilution in Fig. 3B and C with Fig. 1B).
urthermore, analysis of the 10-fold dilutions indicated some
ariability due to low level cytokine mRNA expression (such as for
L1, IFN). Use of 2-fold dilutions of the cDNA standards enabled
he efﬁciency to be determined and data points overlaid with the
ata points generated by the 10-fold dilution series, suggesting
his approach is acceptable to determine cytokine levels (Fig. 3A).
o minimize the potential effect of initial sampling variability,ribed in bulk and assayed detecting ATF4, in four separate real time PCR reactions.
 using linear regression.
a calculation of gene stability was performed for housekeeping
genes (Vandesompele et al., 2002). Assessment of the stability of
expression of housekeeping genes following stimulation with dif-
ferent mitogens (Fig. 4A) or inﬂuenza virus (Fig. 4B) demonstrated
that expression of some housekeeping genes, such as GAPDH, was
affected more than others and this effect was  speciﬁc to different
stimuli (compare Fig. 4A to B). As GAPDH was  more variable in
expression than the other housekeeping genes; ATF4, L32 and
HPRT following mitogen stimulation, GAPDH was excluded and a
combination housekeeping genes was  used as a reference (Fig. 4C).
In contrast, following virus stimulation, all housekeeping genes
were relatively stable and thus all housekeeping genes were able
to be used as references (Fig. 4D). These data suggests that reaction
efﬁciencies and the most stable housekeeping genes should be
determined for a type of sample set of cDNA under analysis to be
able to accurately calculate gene expression.
3.3. Stimulation of ferret lymph node cells with mitogens or
inﬂuenza virus differentially modulates expression of innate and
adaptive immune mediators
To test the ability of ferret leukocytes to produce mRNA
cytokines and chemokines, lymph node cells from naïve ferrets
were cultured with various mitogens known to activate T and
B lymphocyte and macrophage/monocyte responses (Fig. 5) and
with live or heat inactivated inﬂuenza virus (Fig. 6) and the
cytokine and chemokine expression proﬁles were determined
(summarized in Table 4). Culture with the lectins Concanavalin A
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Fig. 3. Assessment of efﬁciency of TaqMan assay for ferret cytokine mRNAs using cDNA. The efﬁciency of each reaction was determined using standard curves generated
from  cDNA pools in 10-fold or 2-fold dilution series (average of duplicate values are shown). (A) Examples of calculations for efﬁciency using cDNA standards from mitogen-
stimulated cells to detect IL1 and IL8 expression. (B, C) The reaction efﬁciencies for each gene for a set of cDNA standards (10-fold and 2-fold dilutions) were calculated.
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utliers are indicated by white squares, all other genes are indicated by black circle
fﬁciency (E) are indicated.
ConA) or Phytohaemagglutinin (PHA), which act by cross linking
 cell receptors via sugars on the surface of human T lymphocytes
Chilson and Kelly-Chilson, 1989), induced similar cytokine pro-
les, increasing expression of IL2, IL4, IL6, IL10, IL17, Granzyme
, TNF and IFN,  most with high fold changes, consistent with
ffective stimulation of T lymphocytes (Fig. 5). PHA also induced
xpression of IL12p40 mRNA. The addition of Con A or PHA
igniﬁcantly reduced the expression of MCP-1 and IFN in their
espective cultures (Fig. 5). Ionomycin and Phorbol 12-myristate
3-acetate (PMA) are mitogenic for lymphocytes as they bypass
urface receptors and activate cellular responses by increasing
ntracellular calcium and directly activating protein kinase C,
espectively (Nishezuka, 1984; Al Wabel et al., 1993). Culture withcells. Housekeeping genes (ATF4, HPRT, GAPDH, L32) are indicated by white circles,
n is indicated for each group by horizontal line. The % efﬁciency and corresponding
ionomycin signiﬁcantly increased mRNA expression of IL2, IL10
and IFN. PMA  signiﬁcantly increased levels of TNF and IL1.
Expression of IFN and IL12p40 mRNAs was signiﬁcantly reduced
upon culture with Ionomycin or PMA  (Fig. 5).
Lipopolysaccharide (LPS) is a potent activator of naïve and
mature B lymphocytes (Andersson et al., 1973; Smith et al., 1979),
monocytes and macrophages. Stimulation with LPS induced sig-
niﬁcant levels of IL6 and a small increase in expression of IL8.
No expression of IFN was detected in any culture stimulated
with mitogen. Real time PCR assays performed as duplex PCRs
with the same primer pairs as shown in Fig. 1E detected up-
and down-regulation of the same cytokines as assays using sin-
gle primer/probe sets (data not shown). Real time assays run with
L.A. Carolan et al. / Journal of Virological Methods 205 (2014) 38–52 47
A B
C D
20
22
24
26
28
30 p<0.00 1
20
22
24
26
28
30 p<0.001
22
24
26
28
30
32 p<0.00 1
none ConA PHA Iono PMA LPS
26
28
30
32
34
36 p<0.00 1
GAPDH ATF4 L32 HPRT
0.6
0.8
1.0
1.2
1.4
1.6
1.8
2.0
2.2
2.4
M
A
T
F
4
G
A
P
D
H
H
P
R
T
L
3
2
Ct
20
22
24
26
28
30 p<0.001
20
22
24
26
28
30 p<0.01
26
28
30
32
34
36 p<0.05
none virus HI virus
28
30
32
34
36
38 p=0.503 4
HPRT GAPDH L32 ATF4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
2.0
2.2
2.4
Fig. 4. Assessment of housekeeping gene expression in cultured ferret lymphoid cells. Expression of housekeeping genes was determined in lymph node cells from naïve
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data  point represents the mean Ct of the culture wells for a single ferret. (A, B) Mean for each group is indicated by horizontal line and p value indicates overall differences
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fetween  groups. (C, D) The ‘average pairwise variation of a gene with all other hou
sing  geNorm (Vandesompele et al., 2002). The least stable gene is shown on the le
0-fold less cDNA (1 ng RNA/l cDNA) for IL6, IFN, L32 and ATF4
etected the same fold differences (data not shown).Culture of ferret leukocytes with live or heat inactivated
(H1N1)pdm09 virus for 48 h induced different cytokine proﬁles
rom those stimulated by mitogens (Fig. 6). Live A(H1N1)pdm09ping genes’ (M)  after stepwise exclusion of the more variable genes as calculated
 most stable gene on the right.
virus induced a signiﬁcant reduction in expression of IL1, IL1,
IL8 and MCP1, as well as large increases in expression of Granzyme
A, IFN and IFN, whereas heat inactivated virus induced negligi-
ble effect on cytokine expression. Note that cultures assayed at 24
and 72 h also showed similar results (data not shown).
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Fig. 5. Gene expression in mitogen-stimulated ferret lymph node cells. Lymph node cells from four naïve ferrets were stimulated with the indicated mitogens for 24 h, then
RNA  was  isolated, reverse transcribed and assayed by real time PCR using 10 ng initial 
triplicate culture wells compared to the geometric mean of L32, HPRT and ATF4 housek
group;  dotted line indicates no fold change. Statistical difference in fold-change compare
Table 4
Changes in cytokine and chemokine expression following stimulation of ferret
lymph node cells with mitogens or inﬂuenza virus.
Gene Stimulus
ConA PHA Iono PMA  LPS Inﬂuenza virus
IL1 nca nc nc +b + ↓***
IL1 nc nc nc +*d + ↓***
IL2 +*** +*** +*** + nc nc
IL4  +* +** + + nc nc
IL6  +* + nc ↓c +* nc
IL8  nc nc nc + + ↓***
IL10 +*** + +** nc + nc
IL12p40 nc +** ↓* ↓*** nc nc
IL17 + + + nc nc nc
Granzyme A +** + + + nc +**
MCP1 ↓** ↓* ↓ nc nc ↓**
TNF +*** + ↓ +** nc nc
IFN  ↓** ↓** ↓** ↓** ↓ +**
IFN  n.d.e n.d. n.d. n.d. n.d. nc
IFN  +*** +* +*** nc nc +***
a No change in expression compared to unstimulated cells.
b Upregulation in expression compared to unstimulated cells.
c Down-regulation in expression compared to unstimulated cells.
d Signiﬁcant change *p < 0.05, **p  < 0.01, ***p < 0.001.
e Not detected.RNA/reaction. Each data point represents the average fold change of duplicate or
eeping genes. IFN was  not detected. Horizontal bars indicate the mean for each
d to cells with no stimulation is indicated.
4. Discussion
In this study, we describe a series of real time TaqMan RT-PCR
assays that can be used to characterize the expression of cytokines
and chemokines of the innate and adaptive immune response in
ferrets. The sequences of the ferret genes cloned in this study and
used for design of the primers and probes, aligned with other previ-
ously published sequences as well as with the predicted sequences
from the Ferret Genome Project (Di Palma et al., 2013). Previous
studies have predominantly utilized SYBR green real time RT-PCR
and required a minimum quantity of 10 ng initial RNA per reaction
for detection of a single ferret cytokine or chemokine (Svitek et al.,
2008; Meunier et al., 2012; Meunier and von Messling, 2012). Here
we have demonstrated that 1 ng total RNA is sufﬁcient in a Taq-
Man  real time RT-PCR assay to detect most cytokine and chemokine
mRNAs. By multiplexing reactions with probes using different ﬂu-
orochromes, samples with low amounts of RNA, such as ferret
respiratory samples (Suguitan et al., 2012), may still be analyzed
using this assay without loss of sensitivity, providing a signiﬁcant
sample and cost reduction. In our study we showed that a mini-
mum of duplex assays could be used, mixing primers and probes
speciﬁc for a housekeeping gene and a cytokine/chemokine gene
or two cytokine/chemokines genes. With further optimization, a
higher number of targets may  be able to be multiplexed.
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Real time PCR results can be reported in copy number or as fold
hange both compared to a control, depending on whether absolute
r relative quantiﬁcation is required (Giulietti et al., 2001; Pfafﬂ,
004). Absolute quantiﬁcation requires DNA or in vitro transcribed
NA standards to be included in each reaction, whereas relative
uantiﬁcation can be achieved by including a set of cDNA stan-
ards generated from the sample of interest, or no standards at all,
f the efﬁciency of each reaction is identical (Pfafﬂ, 2004). As it is
ifﬁcult to maintain the stability of a large number of RNA stan-
ards (Giulietti et al., 2001), absolute quantiﬁcation was not used
n this study. Furthermore, the necessity for a standard curve on
ach assay plate would increase the number of plates required for
n experiment, which may  become impractical when assaying a
arge number of test samples. Calculation of fold change relativen of GAPDH, L32, HPRT and ATF4 housekeeping genes. The inﬂuenza A matrix gene
enes had a detectable Ct in all samples. Horizontal bars indicate the mean for each
d to cells with no stimulation is indicated.
to housekeeping gene(s), with kinetic PCR efﬁciency adjustment,
incorporates corrections for reverse transcription efﬁciency and
PCR efﬁciency, as well as individual sample addition, by using
normalizer housekeeping genes. In our study, although initial
assays using DNA plasmids demonstrated that the efﬁciencies of
all primer/probe sets in the TaqMan real time PCR assays were
consistent, data from cultures of ferret lymph nodes and our pre-
liminary data with ferret respiratory samples (not shown) indicate
that the efﬁciency of reactions clusters for each set of cDNAs and
appropriate housekeeping genes need to be determined for each
sample type. The importance of careful assessment of suitable
housekeeping genes for real time PCR has also been demonstrated
for human, canine and ferret tissues (Peters et al., 2007; Mane
et al., 2008; Bruder et al., 2010). As real time PCR measures the
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t in the exponential phase of the PCR, it has been argued that
he effect of differences in PCR efﬁciency is minor (Giulietti et al.,
001). However, we anticipate this TaqMan assay will be useful for
arious ferret samples, particularly nasal washes or bronchoalveo-
ar lavages, and respiratory tissues in virus-infected ferrets, which
ay  have low amounts of RNA, and variable levels of expression
f cytokine and chemokine genes. Given the variability in the cel-
ular composition of samples from different sites (e.g. lung tissue
ompared to lymph node), incorporation of corrections for reverse
ranscription and PCR efﬁciency and housekeeping gene variability
re necessary in these samples.
The cytokine proﬁles induced by stimulation of lymph node
ells from naïve ferrets with mitogens were consistent with those
eported in studies using human and other animal leukocytes.
timulation of ferret lymph node cells with ConA induced simi-
ar proﬁles to cultures of mouse splenocytes (Candolﬁ et al., 1995),
uman PBMCs (Al Wabel et al., 1993; Yaqoob and Calder, 1998;
adke et al., 2012), woodchuck PMBCs (Menne et al., 2002) and calf
D4+ and CD8+ PBMCs (Tanaka et al., 2007) stimulated with ConA.
f interest, ConA has been shown to induce expression of IL1 and
ow levels of IL1 in human PBMCs (Yaqoob and Calder, 1998), but
e did not detect increases in either cytokine in ferret lymph node
ells. We  also used the other published primers for detecting IL1
Fang et al., 2010; Rowe et al., 2010) with our samples but could
ot detect expression (data not shown). Increased levels of TNF,
L2 and IFN were reported following culture of human PBMCs with
HA (Godoy-Ramirez et al., 2004; Anderson and Teuber, 2010), and
e obtained similar results using ferrets cells. Ionomycin and PMA
ave been shown to increase production of IL2, IL4 and IFN in
uman PBMCs (Jung et al., 1993) and IL4, IL8, IFN and TNF in
erret BAL, splenocytes or PBLs (Rutigliano et al., 2008; Martel and
asted, 2009); all of these genes were also upregulated in this cur-
ent study following stimulation of ferret leukocytes with either
onomycin or PMA. LPS is a potent stimulator of IL1 and , IL6,
nd TNF from human PBMCs (Al Wabel et al., 1993; Yaqoob and
alder, 1998; Matera et al., 2009; Coch et al., 2013) and IL6 and
NF from mouse PBMCs and macrophages (Kawai et al., 2004).
imilarly, IL1 and , IL6, and IL8, but not TNF, were increased
n LPS-stimulated ferret lymph node cultures. A similar study in
hich ferret PBMCs were cultured with LPS detected expression
f IL6, IFN, IL10 and TNF by TaqMan real time RT-PCR at earlier
imepoints, suggesting the kinetics of the response are important
Nakata et al., 2009). We also assessed TNF expression using
reviously published TaqMan primers and probe (Nakata et al.,
009) and SYBR Green primers (Fang et al., 2010; Rowe et al.,
010) with our samples and the proﬁles were consistent with those
btained with the TaqMan assay designed in this study (data not
hown).
Stimulation of ferret lymph node cultures with live inﬂuenza
irus resulted in upregulated expression of IFN and Granzyme A,
nd these markers of T lymphocyte (and NK cell) activation, are also
pregulated following stimulation of human PBMCs with inﬂuenza
irus (Forbes et al., 2012; Vanders et al., 2013). IL2 was not detected
n ferret cells, although it has been detected by ﬂow cytome-
ry in human cells following in vitro inﬂuenza virus stimulation
Scheible et al., 2011; Guérin-El Khourouj et al., 2012). Increased
xpression of type I interferons (also seen upon virus stimula-
ion in human PBMCs (Forbes et al., 2012)) and a corresponding
ecrease in MCP1 expression was induced in ferret cells follow-
ng exposure to inﬂuenza virus. This inverse relationship has also
een reported in mice co-infected with bacteria and inﬂuenza virus
nd is suggested to be due to type I interferon-mediated suppres-
ion of macrophages (Nakamura et al., 2011). This may  also explain
he reductions in IL1 and IL8 in ferret lymph node cells cultured
ith virus as both these mediators would be typically produced by
acrophages in the lymph node. The signiﬁcant down-regulationcal Methods 205 (2014) 38–52
of IFN and variable expression of MCP-1 and IL12p40 in cultures
stimulated with mitogens may  also be due to altered activation of
cells of the innate immune system. The magnitude and differential
patterns of gene expression detected here indicate that these assays
can be used for more detailed investigations of the cell types and
pathways (Ghosh et al., 2006) that contribute to immune responses
in the ferret.
In summary, we  have described a series of TaqMan real time RT-
PCR assays to quantify a large number of cytokines and chemokines
in the ferret model. Our study highlights key technical aspects
of these assays to maximize the analysis of immune mediators
induced from ferret cells. The particular cytokine and chemokine
proﬁles induced in ferret cells following stimulation with mitogens
or inﬂuenza virus were consistent with those reported for other
species. Overall these data demonstrate the usefulness of these
assays to enhance our understanding of inﬂuenza virus infection
and other diseases that use the ferret model.
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